Therapeutic targeting of the mTOR/HIF-1α/glycolysis pathway in TREM-1-activated macrophages could be beneficial for treating or preventing inflammatory diseases, such as ALI. This evidence concerns the gene HIF1A and acute respiratory distress syndrome.